Canagliflozin for Prevention of Cardiovascular and Renal Outcomes in type2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled TrialsLei Tian, Yaoxian Wang, Jingyi Tang et al.|Frontiers in Pharmacology|2021Cited by 32
Cardiovascular and renal outcomes with sodium glucose co-transporter 2 inhibitors in patients with type 2 diabetes mellitus: A system review and network meta-analysisLei Tian, Yaoxian Wang, Mengqi Zhou et al.|Frontiers in Pharmacology|2022Cited by 9